Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1998 Jun;89(6):666–672. doi: 10.1111/j.1349-7006.1998.tb03269.x

Cytotoxic Mechanisms of FK317, a New Class of Bioreductive Agent with Potent Antitumor Activity

Yoshinori Naoe 1,✉, Masamichi Inami 1, Ikuo Kawamura 1, Fusako Nishigaki 1, Susumu Tsujimoto 1, Sanae Matsumoto 1, Toshitaka Manda 1, Kyoichi Shimomura 1
PMCID: PMC5921879  PMID: 9703365

Abstract

FK317 is a member of a new class of bioreductive agents that exhibit strong cytotoxicity against various human cancer cells. The effect of FK317 was found to be stronger than that of mitomycin C (MMC), adriamycin (ADR) or cisplatin (CDDP). Alkaline elution analysis indicated that FK317 formed interstrand DNA‐DNA and DNA‐protein cross‐links in cells. On the other hand, no DNA single‐strand breaks were observed in the cells treated with FK317. In a cell‐free system the deacetylated metabolites produced cross‐linked DNA under reductive conditions, though FK317 itself did not form DNA‐DNA cross‐links. In order to elucidate the metabolic activation mechanisms, we established an FK317‐resistant subline from human non‐small cell lung cancer cells (Lu99) by stepwise and brief exposure (1 h) to FK317. The resistant subline (Lu99/317) showed cross‐resistance to MMC and carboquone (CQ), but not to ADR or CDDP. DT‐diaphorase, which is one of the activation enzymes of MMC and CQ, was deficient in Lu99/317 cells as determined by enzyme activity assay. However, the levels of NADPH:cytochrome P450 reductase, which is another activation enzyme for MMC and CQ, were comparable in resistant and parent cell lines. Treatment of the cells with dicumarol, an inhibitor of DT‐diaphorase, reduced the cytotoxicity of FK317 to Lu99 cells, but not to Lu99/317 cells. These results indicate that deacetylation of FK317 is necessary for its reductive activation, and deacetylated FK317 is reduced by DT‐diaphorase to form an active metabolite, which produces DNA‐DNA interstrand and DNA‐protein cross‐links that lead to cell death.

Keywords: key words, FK317, Antitumor effect, Bioreductive agent, DT‐diaphorase, Deacetyl metabolite

Full Text

The Full Text of this article is available as a PDF (182.8 KB).

REFERENCES

  • 1. ) Shimomura , K. , Manda , T. , Mukumoto , S. , Masuda , K. , Nakamura , T. , Mizota , T. , Matsumoto , S. , Nishigaki , F. , Oku , T. , Mori , J. and Shibayama , F.Antitumor activity and hematotoxicity of a new, substituted dihydro‐benzoxazine, FK973, in mice . Cancer Res. , 48 , 1166 – 1172 ( 1988. ). [PubMed] [Google Scholar]
  • 2. ) Majima , H. , Hasegawa , K. , Fukuoka , M. , Furuse , K. , Wakui , A. , Furue , H. , Masaoka , T. , Hattori , T. , Taguchi , T. , Ogura , T. and Niitani , H.Phase I clinical and pharma‐cokinetic study of FK973 . Proc. Am. Soc. Clin. Oncol. , 9 , 78 ( 1990. ). [Google Scholar]
  • 3. ) Pazdur , R. , Ho , D. H. , Daugherty , K. , Bradner , W. T. , Krakoff , I. H. and Raber , M. N.Phase I trial of FK973: description of a delayed vascular leak syndrome . Invest. New Drugs , 9 , 337 – 382 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Lin , A. J. , Cosby , L. and Sartorelli , A. C.Potential bioreductive alkylating agents . In“Cancer Chemotherapy,” ed. Sartorelli A. C. , pp. 71 – 80 ( 1976. ). ACS Monograph Series; , Washington , DC . [Google Scholar]
  • 5. ) Tomasz , M. , Lipman , R. , Chowdary , D. , Pawlak , J. , Verdine , G. L. and Nakanishi , K.Isolation and structure of a covalent cross‐link adduct between Mitomycin C and DNA . Science , 235 , 1204 – 1208 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Long , B. H. , Willson , J. K. V. , Brattain , D. E. , Musial , S. and Brattain , M. G.Effects of mitomycin on human colon carcinoma cells . J. Natl. Cancer Inst. , 73 , 787 – 792 ( 1984. ). [PubMed] [Google Scholar]
  • 7. ) Mosmann , T.Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays . J. Immunol. Methods , 65 , 55 – 63 ( 1983. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Kohn , K. W. , Ewig , R. A. G. , Erickson , L. C. and Zwelling , L. A.Measurement of strand breaks and cross links by alkaline elution . In“DNA Repair,” ed. Friedberg E. C. and Hanowalt P. C. , pp. 379 – 401 ( 1981. ). Marcel Dekker, Inc. , New York . [Google Scholar]
  • 9. ) Williams , R. M. and Scott , R. R.DNA cross‐linking studies on FR900482: observations on the mode of activation . Tetrahedron Lett. , 33 , 2929 – 2932 ( 1992. ). [Google Scholar]
  • 10. ) Ernster , L.DT‐diaphorase . Methods Enzymol. , 10 , 309 – 317 ( 1967. ). [Google Scholar]
  • 11. ) Benson , A. M. , Hunkler , M. J. and Talalay , P.Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity . Proc. Natl. Acad. Sci. USA , 77 , 5216 – 5220 ( 1980. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. ) Vermillion , V. L. and Coon , M. I.Purified liver microsomal NADPH‐cytochrome P450 reductase . J. Biol. Chem. , 253 , 2694 – 2704 ( 1978. ). [PubMed] [Google Scholar]
  • 13. ) Naoe , Y. , Inami , M. , Matsumoto , S. , Nishigaki , F. , Tsujimoto , S. , Kawamura , I. , Miyayasu , K. , Manda , T. and Shimomura , K.FK317; a novel substituted dihydrobenzoxazine with potent antitumor activity and without inducing vascular leak syndrome . Cancer Chemother. Pharmacol . ( 1998. ), in press . [DOI] [PubMed]
  • 14. ) Kohn , H.Studies concerning the mechanism of electrophilic substitution reaction of mitomycin C . J. Am. Chem. Soc. , 105 , 4105 – 4106 ( 1983. ). [Google Scholar]
  • 15. ) Pan , S. S. , Andrews , P. A. and Glover , C. J.Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH‐cytochrome P‐450 reductase and xanthine oxidase . J. Biol. Chem. , 259 , 959 – 966 ( 1984. ). [PubMed] [Google Scholar]
  • 16. ) Bligh , H. F. J. , Bartoszek , A. , Robson , C. N. , Hickson , I. D. , Kasper , C. B. , Beggs , J. D. and Wolf , C. R.Activation of mitomycin C by NADPH:cytochrome P‐450 reductase . Cancer Res. , 50 , 7789 – 7792 ( 1990. ). [PubMed] [Google Scholar]
  • 17. ) Keyes , S. R. , Fracasso , P. M. , Heimbook , D. C. , Rockwell , S. , Sligar , S. G. and Sartorelli , A. C.Role of NADPH:cytochrome c reductase and DT‐diaphorase in the biotransformation of mitomycin C . Cancer Res. , 44 , 5638 – 5643 ( 1984. ). [PubMed] [Google Scholar]
  • 18. ) Siegel , D. , Beall , H. , Senekowitsch , C. , Kasai , M. , Arai , N. , Gibson , N. W. and Ross , D.Bioreductive activation of mitomycin C by DT‐diaphorase . Biochemistry , 31 , 7879 – 7885 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 19. ) Marshall , R. S. , Paterson , M. and Rauth , A. M.DT‐diaphorase activity and mitomycin C sensitivity in non‐transformed cell strains derived from members of a cancer‐prone family . Carcinogenesis , 12 , 1175 – 1180 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Keyes , S. R. , Rockwell , S. and Sartorelli , A. C.Enhancement of mitomycin C cytotoxicity to hypoxic tumor cells by dicumarol in vivo and in vitro . Cancer Res. , 45 , 213 – 216 ( 1985. ). [PubMed] [Google Scholar]
  • 21. ) Malkinson , A. M. , Siegel , D. , Forrest , G. L. , Gazdar , A. F. , Oie , H. K. , Chan , D. C. , Bunn , P. A. , Mabry , M. , Dykes , D. J. , Harrison , S. D. , Jr. and Ross , D.Elevated DT‐diaphorase activity and messenger RNA content in human non‐small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin C . Cancer Res. , 52 , 4752 – 4757 ( 1992. ). [PubMed] [Google Scholar]
  • 22. ) Schlager , J. J. and Powis , G.Cytosolic NAD(P)H: (quinone‐acceptor) oxidoreductase in human normal and tumor tissue: effects of cigarette smoking and alcohol . Int. J. Cancer , 45 , 403 – 409 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 23. ) Knox , R. J. , Boland , M. P. , Friedlos , F. , Coles , B. , Southan , C. and Roberts , J. J.The nitroreductase enzyme in Walker cells that activates 5‐(aziridin‐1‐yl)‐2,4‐dinitrobenzamide (CB 1954) to 5‐(aziridin‐1‐yl)‐4‐hydroxylamino‐2‐nitro‐benzamide is a form of NAD(P)H dehydrogenase (quinone) (EC 1.6.99.2) . Biochem. Pharmacol. , 37 , 4671 – 4677 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 24. ) Boland , M. P. , Knox , R. J. and Roberts , J. J.The differences in kinetics of rat and human DT diaphorase results in a differential sensitivity of derived cell lines to CB 1954 (5‐(aziridin‐1‐yl)‐2,4‐dinitrobenzamide) . Biochem. Pharmacol. , 41 , 867 – 875 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 25. ) Fukuyama , T. and Goto , S.Synthetic approaches toward FR‐900482. I. Stereoselective synthesis of a pentacyclic model compound . Tetrahedron Lett. , 47 , 6491 – 6494 ( 1989. ). [Google Scholar]
  • 26. ) Masuda , K. , Nakamura , T. , Shimomura , K. , Shibata , T. , Terano , H. and Kohsaka , M.A new antitumor antibiotic, FR‐900482: V: Interstrand DNA‐DNA cross‐links in L1210 cells . J. Antibiot. (Tokyo) , 41 , 1497 – 1501 ( 1988. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES